Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

RIFAMPICIN - ANVISA Registration 81086830086

Access comprehensive regulatory information for RIFAMPICIN in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 81086830086 and manufactured by BEIJING DIAGREAT BIOTECHNOLOGIES CO., LTD.. The registration is held by FASTTEST DISTRIBUIDORA DE PRODUTOS PARA LABORATร“RIOS LTDA with validity until currently active (VIGENTE).

This page provides complete technical specifications for this device, regulatory compliance details. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
81086830086
Registration Details
ANVISA Registration Number: 81086830086
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Device Details

Rifampicin Determination Kit
Risk Class II

Registration Details

81086830086

25351938432202411

20037992000139

Company Information

China
PT: CHINA, REPรšBLICA POPULAR

Dates and Status

Feb 05, 2024

VIGENTE

09/18/2025 19:00:01